Fresenius | FRE - 销售和管理费用





销售和管理费用 更改 日
Akzo Nobel EUR 804M 7M 2026-03
Alcon AG USD 882M 19M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
BASF EUR 2.13B 84M 2026-03
Bayer EUR 3.7B 356M 2026-03
Beiersdorf EUR 271M 51M 2025-12
DaVita Healthcare Partners USD 421.91M 50.45M 2026-03
Demant DKK 6.09B 135M 2025-12
E.ON EUR -1.71B 3.63B 2025-06
Essilor EUR 5.62B 4.53B 2025-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
Getinge SEK 2.65B 452M 2024-12
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
GN Store Nord DKK 763M 688M 2026-03
GRIFOLS EUR 281M 5.7M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Merck EUR 1.52B 80M 2026-03
Novartis USD 3.14B 296M 2026-03
Philips EUR 1.18B 121M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
RWE EUR 690M 84M 2025-03
Sanofi EUR 2.33B 419M 2026-03
Smith & Nephew USD 1.42B 65M 2025-12